Handa Drug Patent Portfolio
Handa owns 1 orange book drug protected by 5 US patents Given below is the list of Handa's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11202778 | Amorphous solid dispersions of dasatinib and uses thereof | 22 Jan, 2041 | Active |
| US11298356 | Amorphous solid dispersions of dasatinib and uses thereof | 22 Jan, 2041 | Active |
| US11324745 | Amorphous solid dispersions of dasatinib and uses thereof | 22 Jan, 2041 | Active |
| US12433891 | Amorphous Solid Dispersions Of Dasatinib And Uses Thereof | 22 Jan, 2041 | Active |
| US12465606 | Amorphous Solid Dispersions Of Dasatinib And Uses Thereof | 22 Jan, 2041 | Active |
Latest Legal Activities on Handa's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Handa.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Application Is Considered Ready for Issue | 11 Sep, 2025 | US12433891 |
| Dispatch to FDC | 11 Sep, 2025 | US12433891 |
| Issue Fee Payment Received | 09 Sep, 2025 | US12433891 |
| Issue Fee Payment Verified | 09 Sep, 2025 | US12433891 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Sep, 2025 | US11324745 |
| Information Disclosure Statement considered | 08 Sep, 2025 | US12465606 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Sep, 2025 | US11298356 |
| Email Notification | 05 Aug, 2025 | US12433891 |
| Mail Notice of Allowance | 05 Aug, 2025 | US12433891 |
| Notice of Allowance Data Verification Completed | 04 Aug, 2025 | US12433891 |
| Information Disclosure Statement considered | 16 Jul, 2025 | US12433891 |
| Date Forwarded to Examiner | 14 Jul, 2025 | US12433891 |
| Information Disclosure Statement (IDS) Filed | 07 Jul, 2025 | US12433891 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED | 07 Jul, 2025 | US12433891 |
| Terminal Disclaimer Filed | 07 Jul, 2025 | US12433891 |
Handa's Family Patents
Handa Drug List
Given below is the complete list of Handa's drugs and the patents protecting them.
1. Phyrago
Phyrago is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11202778 | Amorphous solid dispersions of dasatinib and uses thereof |
22 Jan, 2041
(14 years from now)
| Active |
| US11298356 | Amorphous solid dispersions of dasatinib and uses thereof |
22 Jan, 2041
(14 years from now)
| Active |
| US11324745 | Amorphous solid dispersions of dasatinib and uses thereof |
22 Jan, 2041
(14 years from now)
| Active |
| US12433891 | Amorphous Solid Dispersions Of Dasatinib And Uses Thereof |
22 Jan, 2041
(14 years from now)
| Active |
| US12465606 | Amorphous Solid Dispersions Of Dasatinib And Uses Thereof |
22 Jan, 2041
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Phyrago's drug page